Past pandemics have seen the predominance of only one influenza strain. The H1N1 virus Replikin Count, as of April 7, 2010, has not returned to pre-outbreak levels, but in fact is rising. At the same time, the H5N1 virus Replikin Count continues to rise in a third cycle, as predicted by H9N2-H5N1 data one year ago (replikins, Replikins Press, January 15, 2009), and now realized in new outbreaks of H5N1 reported in 63 countries (CIDRAP, March 23, 2010), with 22 human cases, 8 fatal this year (WHO, March 30, 2010). Egypt has reported 16 human cases, of which 5 have been fatal (CIDRAP, March 15, 2010). Vietnam has had 2 lethalities (Reuters, March 18, 2010).

Replikins, Ltd. has produced a Synthetic Replikins Vaccine, TransFlu?„?, with elements against both H5N1 and H1N1. In an independent trial, TransFlu?„? vaccine has blocked H5N1 in chickens (doi: Avian Diseases 10.637/8892-042509-ResNote.1). This is one example of the function of the BioRadar?„? system of "Early Detection->Rapid Response." Formulation of the TransFlu?„? vaccine began over one year ago, based on H5N1 Replikins Analysis, when the increase in H5N1 virus Replikin Count predicted the present H5N1 outbreaks.

SOURCE Replikins, Ltd.